Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Manipulating the gut microbiome to decrease uremic toxins.

Kidney international - 1 Mar 2017

Yacoub Rabi, Wyatt Christina M

Abstract excerpt

The uremic solute indoxyl sulfate has been associated with increased mortality and other adverse outcomes in patients with chronic kidney disease. In a recent study published in Cell Host & Microbe, Devlin et al. describe a novel approach to alter the production of indoxyl sulfate through manipulation of the gut microbiota. Although this approach is far from clinical application, it may allow investigators to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteroides
Share to Gastrointestinal Microbiome
Share to Gastrointestinal Tract

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Mutation

Share to Phenotype

Share to Uremia

Source

Identifiers

PMID: 28202164
DOI: 10.1016/j.kint.2017.01.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Manipulating the gut microbiome to decrease uremic toxins.PMID 28202164Read ↗

Chronic kidney disease and the gut microbiomeSemantic proximity Read ↗

Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut MicrobiotaSemantic proximity Read ↗

Role of the Gut Microbiome in Uremia: A Potential Therapeutic TargetSemantic proximity Read ↗

Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug TransportersSemantic proximity Read ↗

Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney DiseaseSemantic proximity Read ↗

Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing UremiaSemantic proximity Read ↗

The Microbiome and p-Inulin in Hemodialysis: A Feasibility StudySemantic proximity Read ↗

Microcystin-LR exacerbates chronic kidney disease in rats: insights into gut microbiome and host proteome dysregulationSemantic proximity Read ↗

Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and MetabolismSemantic proximity Read ↗

Microbiome in Chronic Kidney Disease (CKD): An Omics PerspectiveSemantic proximity Read ↗

Gut microbial-derived short chain fatty acids enhance kidney proximal tubule cell secretory functionSemantic proximity Read ↗

Guidelines for microbiome studies in renal physiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.